Logotype for Société de la Tour Eiffel

Société de la Tour Eiffel (EIFF) H2 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Société de la Tour Eiffel

H2 2025 earnings summary

2 Mar, 2026

Executive summary

  • EPRA earnings for 2025 were €17.4m, with recurring cash flow at €19.3m and a suspension of the dividend.

  • The portfolio value declined 6.4% like-for-like to €1.6bn, with 132 buildings and a 74.5% occupancy rate.

  • Strategic focus remained on rental activity (€18.2m signed/renewed), developments (€66.7m), and selective disposals (€2.8m).

  • Maintained strategic momentum and rigorous operational management amid a polarized French real estate market, with office take-up down 9% year-over-year.

  • Raised €598.8m in January 2025, strengthening the balance sheet and enabling further development and risk management.

Financial highlights

  • Gross rental income fell to €74.7m from €79.0m year-over-year; net rental income was €58.8m.

  • Consolidated net loss widened to -€63.9m from -€59.2m year-over-year.

  • EPRA earnings dropped to €17.4m (€0.14/share) from €21.9m (€0.17/share) pro forma.

  • EPRA NTA per share was €8.2, EPRA NDV per share €8.1, and EPRA NRV per share €8.9.

  • EPRA cost ratio (including direct vacancy) increased to 45.5%.

Outlook and guidance

  • The company is focusing on strengthening its financial structure, rebalancing the portfolio, and restoring sustainable distribution capacity.

  • Management expects ICR ratio to remain close to or below the 2x covenant in 2026, with amendments already secured for compliance.

  • Focus remains on ramping up recently delivered assets, continued divestments, and further portfolio diversification.

  • Dividend suspension proposed to continue, with a long-term goal to restore and increase distributions as conditions allow.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more